| Name | Title | Contact Details |
|---|
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
Mxe Inc is a Culver City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CNS Response, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Community Care Behavioral Health Organization is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Delaware Hospice is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Wilmington, DE. To find more information about Delaware Hospice, please visit www.delawarehospice.org